Biotech
Peptide therapeutics company targets age-related disease
Gray Matter working with Insilico Medicine to identify peptide targets and accelerate development timeline...
Buck researchers provide a framework to study precision nutrigeroscience
One size doesn't fit all – a new research sub-specialty deals with the fact that health benefits from many forms of dietary restriction vary...
Accelerating antiaging research by hacking longevity
Bringing together aging researchers, developers and entrepreneurs, the Longevity Hackathon aims to build new tools, raise awareness and attract talent to the field.
Kicking off...
Latest news
X marks the spot for meaningful information on aging and cognition
Understanding chromosomal differences between men and women could be the X Factor when it comes to tackling cognitive decline.
A new paper published in Jama...
SENS spin-out Underdog closes $10m financing round
Underdog Pharmaceuticals, a key investment of rejuvenation biotech VC Kizoo, has closed a $10 million round of capital.
Michael Greve’s Kizoo Technology Capital Group led the...
Unlocking ovarian aging could prolong fertility and delay menopause
Ovarian aging is poorly understood, under-researched and under-invested. We need a radical rethink of how we address fertility and the menopause – it's time...
Occuity raises over £2.5m for optical diabetes devices
UK MedTech firm Occuity successfully raises over £2.5m to deliver ophthalmic and optical diabetes devices and is now overfunding on Seedrs to accelerate development.
DISCLOSURE:...
Fauna closes $9 million to expand drug discovery platform
Leveraging animal genomics to improve human health, Fauna Bio set to expand its comparative genomics platform for novel target drug discovery.
Silicon Valley biotech startup...
Diagnostics
Occuity raises over £2.5m for optical diabetes devices
UK MedTech firm Occuity successfully raises over £2.5m to deliver ophthalmic and optical diabetes devices and is now overfunding on Seedrs to accelerate development.
DISCLOSURE:...
Eyes provide early view of Alzheimer’s risk
Protein deposits in the retina and brain appear to parallel possible neurodegeneration, an insight that might lead to easier, quicker detection.
Amyloid plaques are protein...
Predicting possible Alzheimer’s with nearly 100% accuracy
Researchers develop a deep learning-based method that can predict the possible onset of Alzheimer's disease from brain images with an accuracy of over 99%.
Researchers...
Biotech
Shifting gear: startup aims to de-risk rejuvenation therapy
Shift Bioscience raising funding to develop safe cellular reprogramming...
Senolytic cocktail reduces aging-associated disc degeneration
Senolytic drug therapies that target aging cells early pave...
Bezos billions fund new antiaging biotech start-up
Longevity steps centre-stage as Jeff Bezos and Yuri Milner...
ARDD 2021 wraps up
ARDD 2021: Biological age from wearables, ripple effects on...
Investment
SENS spin-out Underdog closes $10m financing round
Underdog Pharmaceuticals, a key investment of rejuvenation biotech VC Kizoo, has closed a $10 million round of capital.
Michael Greve’s Kizoo Technology Capital Group led the...
Unlocking ovarian aging could prolong fertility and delay menopause
Ovarian aging is poorly understood, under-researched and under-invested. We need a radical rethink of how we address fertility and the menopause – it's time...
Occuity raises over £2.5m for optical diabetes devices
UK MedTech firm Occuity successfully raises over £2.5m to deliver ophthalmic and optical diabetes devices and is now overfunding on Seedrs to accelerate development.
DISCLOSURE:...
Fauna closes $9 million to expand drug discovery platform
Leveraging animal genomics to improve human health, Fauna Bio set to expand its comparative genomics platform for novel target drug discovery.
Silicon Valley biotech startup...
Targeting cognitive decline with medical food
Mitocholine raising funding for clinical trial of nutritional compound that addresses cognitive decline by bridging the ‘brain energy gap’.
DISCLOSURE: Longevity.Technology (a brand of First...
Most popular articles
Tree of Longevity – understanding how supplements work
Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan.
Longevity supplements differ from other 'generic supplements' as...
An antiaging supplement that also reduces appetite?
One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation.
A researcher at the...
Berberine could be longevity’s “best-kept secret”
From tackling senescence to lowering blood sugar, berberine is the supplement with a host of tricks up its sleeves.
Berberine is a bioactive compound found...
Spermidine: the mind-enhancing supplement
Scientists are finding that a high intake of dietary spermidine could slow down (or reverse) the brain aging process.
Memory loss and slower brain function...
Sticking with glutathione could be a smart longevity choice
The body's "master antioxidant" glutathione is a powerful weapon in the fight for longevity, but it diminishes with age; AgelessRx has a range of...
Video
The Sheekey Science Show – restoring brain health with bacteria
Phil Newman - 0
The Sheekey Science Show explains how the relationship between your gut and your brain can improve your lifespan and healthspan from top to toe.
You...
Mike Murphy on mitochondria and keeping them healthy
The Co-Creator of MitoQ, Professor Mike Murphy, dives into the science behind mitochondrial health and the relationship with aging.
Mike Murphy is Professor of Mitochondrial...
The Sheekey Science Show – VEGF
Phil Newman - 0
VEGF to extend lifespan? (targeting vascular aging)
"A Man is as old as his arteries". This famous quote from English physician Thomas Sydenham depicts how...
The Sheekey Science Show – Aging Clocks
Phil Newman - 0
Aging clocks - how to measure biological age.
I hope you have some time on you hands as today we will talk all about aging...
Innovation
One protein to rule them all – a central target for treating dementia
Researchers from Tokyo Medical and Dental University predict and confirm a key protein mediator of dementia in frontotemporal lobar...
Building the ovarian environment from stem cells
Researchers successfully reconstitute the ovarian follicle from mouse stem cells.
Researchers led by Kyushu University have succeeded in using mouse...
Economy
Unlocking ovarian aging could prolong fertility and delay menopause
Ovarian aging is poorly understood, under-researched and under-invested. We need a radical rethink of how we address fertility and the menopause – it's time...
Impetus – getting the longevity party started
Propelling longevity research towards maximum impact, the Longevity Impetus Grants have $26m in funding to award.
$26m worth of funding "towards basic research that could...
Location, location… longevity?
Analysis of Medicare data finds location matters, not just past health behaviour, and comparison of seniors who relocate long-distance shows where you live affects...
UK begins consultation to develop pandemic resilience and improve longevity
APPG for Longevity invites contributions to the Open Life Data Framework – aims to make it easier to collect and connect data to help...
Supplements
Targeting cognitive decline with medical food
Mitocholine raising funding for clinical trial of nutritional compound that addresses cognitive decline by bridging the ‘brain energy gap’.
DISCLOSURE: Longevity.Technology (a brand of First...
What everyone ought to know about NMN
There is a whole raft of information about longevity supplements out there, but NMN is one supplement that warrants a closer look. Check out...
An antiaging supplement that also reduces appetite?
One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation.
A researcher at the...
From pioneers to exploders: MitoQ is driven by research
MitoQ is a supplement that's backed by a wealth of research – and they welcome the scrutiny.
Therapies and supplements often reference studies that evidence...
AI/Digital
Peptide therapeutics company targets age-related disease
Gray Matter working with Insilico Medicine to identify peptide...
Shifting gear: startup aims to de-risk rejuvenation therapy
Shift Bioscience raising funding to develop safe cellular reprogramming...
Predicting possible Alzheimer’s with nearly 100% accuracy
Researchers develop a deep learning-based method that can predict...
Agetech
Honor acquires Home Instead – big news for aging in place
Together, Honor and Home Instead plan to transform care experience for caregivers and older adults by empowering the caregiving workforce and increasing innovation to revolutionise...
Student designs smart mobility aid for dementia sufferers
New smart mobility aid will allow people with dementia to live independently for longer and reduce strain on the care system.
According to Alzheimer’s Research UK,...
Senior living tech is now a must-have
K4Connect co-founder reveals how the senior living operators’ views on technology have changed since the arrival of COVID-19.
Agetech company K4Connect this week unveiled a...
Huma’s $130m raise will scale its digital health platform
With the goal of bringing proactive, predictive care to all, Huma has $130 million financing from leading health and technology companies.
The investment arms of...
